Results 61 to 70 of about 1,367,795 (274)

Pure Red Cell Aplasia and Lymphoproliferative Disorders: An Infrequent Association [PDF]

, 2012
Pure red cell aplasia (PRCA) is a rare bone marrow failure syndrome defined by a progressive normocytic anaemia and reticulocytopenia without leukocytopenia and thrombocytopenia.
Ioannis Klonizakis, Elizabeth Ioannidou-Papagiannaki, Efthymia Vlachaki, Styliani Haralambidou-Vranitsa, Michael D. Diamantidis, Philippos Klonizakis   +5 more
core   +1 more source

Lymph Node Ultrasound in Lymphoproliferative Disorders: Where Are We Now?

, 2021
Lymphoproliferative disorders are one of the most frequent hematological malignancies affecting the blood and lymphatic system. To better stratify patients, an accurate imaging evaluation is needed.
Lombardi, Anna, Manzato, Enrica, Tavarozzi, Rita   +2 more
core   +1 more source

Pleiotropic Roles of FBXO11 in Tumorigenesis: Implications for Targeted Therapy

Cancer Science, EarlyView.
This complex comprises of scaffold CUL1, SKP1, RBX1 and FBXO11 receptor. The substrate is phosphorylated by specific kinase enzyme and recognized by the substrate recognition domain. FBXO11 targets numerous substrates for ubiquitination and degradation, FBXO11 substrates mainly include Snail, ZEB1, p53, BCL6, CDT2, CIITA, Cdc25a, hnRNPA2B1, SAMD1 and ...
Yuqi Zhang, Changyi Fan, Shiheng Chen, Tianyue Lu, Yuanyuan Li, Feng Du, Shanshan Wang   +6 more
wiley   +1 more source

Real‐World Safety and Efficacy of Pola‐R‐CHP in Previously Untreated DLBCL: POLASTAR Interim Analysis of 500 Patients

Cancer Science, EarlyView.
In this analysis of a diverse cohort of 500 patients with previously untreated DLBCL in a real‐world clinical setting, Pola‐R‐CHP demonstrated high response rates at end‐of‐treatment, which were consistent among the overall population, in patients > 80 years and regardless of International Prognostic Index status and cell of origin subtypes.
Takahiro Kumode, Hitomi Sawa, Kohta Miyawaki, Atsushi Satake, Nobuhiro Kanemura, Ritsuro Suzuki, Yuki Fujiwara, Yasuhiro Nagate, Shuichi Ota, Takahiro Fujino, Hideki Goto, Noriko Fukuhara, Mamiko Sakata‐Yanagimoto, Koji Izutsu, Momoko Nishikori, Hirohiko Shibayama, Daisuke Ennishi, Takayuki Shimose, Mai Asai, Itaru Matsumura, Koichi Akashi, Koji Kato   +21 more
wiley   +1 more source

Indolent Lymphoproliferative T-Cell Disorders Associated With Gastrointestional Disease: Diagnostic Challenges and Outcomes

, 2022
Lymphoproliferative diseases arise when the physiological mechanisms that control the proliferation of T and B lympho-cytes are disrupted, resulting in an uncontrolled and autonomous increase in immune cells leading to lymphocytosis and lymphadenopathy ...
Tommasina Perrone, Pierluigi Masciopinto, Francesco Gaudio, Longo, Maria Chiara, Eugenio Maiorano, Masciopinto, Pierluigi, Musto, Pellegrino, Ingravallo, Giuseppe, Laddaga, Filomena Emanuela, Arcuti, Elena, Maiorano, Eugenio, Bellitti, Emilio, Battisti, Olga, Elena Arcuti, Giuseppe Ingravallo, Perrone, Tommasina, Olga Battisti, Cazzato, Gerardo, Emilio Bellitti, Pellegrino Musto, Maria Chiara Longo, Gerardo Cazzato, Gaudio, Francesco, Filomena Emanuela Laddaga   +23 more
core   +1 more source

Primary Cutaneous Gamma‐Delta T‐Cell Lymphoma Complicating Long‐Standing Immunosuppressed Dermatomyositis

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Primary cutaneous gamma‐delta T‐cell lymphoma (PCGD‐TCL) is a rare cytotoxic lymphoma with key oncogenic drivers in the JAK/STAT pathway. Also primarily involving the subcutaneous adipose tissue, subcutaneous panniculitis‐like T‐cell lymphoma (SPTCL) is more frequently encountered in scenarios of autoimmune disorders.
Bennett Christie‐Nguyen, Youn H. Kim, David F. Fiorentino, Danielle Tartar, Ryanne Brown, Robert A. Novoa, Kerri E. Rieger   +6 more
wiley   +1 more source

Posttransplant lymphoproliferative disorders following liver transplantation: Where are we now?

, 2015
Liver transplantation has emerged as a life-saving treatment for several patients with acute liver failure, end stage liver disease and primary hepatic malignancies.
Cardinaels, Nina, Dierickx, Daan
core   +1 more source

Elevated lymphoma risk in patients with chronic pruritus and chronic prurigo

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and objectives Chronic pruritus (CP) and chronic prurigo (CPG, including prurigo nodularis) are prevalent, debilitating diseases with diverse comorbidities, including malignancies. This retrospective cohort study evaluated the prevalence and risk of lymphoma in CP and CPG patients, including key risk factors, and sex‐ and ancestry ...
Svenja Royeck, Henning Olbrich, Steffen Koschmieder, Claudia Zeidler, Felix Witte, Konstantin Agelopoulos, Henning Wiegmann, Michael Storck, Johannes Benedict Oehm, Ralf J. Ludwig, Sonja Ständer   +10 more
wiley   +1 more source

Recurrent EBV-negative monomorphic post-transplant lymphoproliferative disorder confined to sequential liver allografts

Transplantation Reports
Post-transplant lymphoproliferative disorder (PTLD) is a heterogeneous spectrum of lymphoproliferative disorders that can develop in the setting of immunosuppression following transplant.
Taylor Viggiano, Amani Elshaer, Hally Chaffin, Bashar Aqel, Michele Barnhill   +4 more
doaj   +1 more source

Occult hepatitis C virus infection in patients with malignant lymphoproliferative disorders

International Journal of Immunopathology and Pharmacology, 2020
Despite the link between HCV and malignant lymphoproliferative disorders has been established, the association between occult hepatitis C virus infection and malignant lymphoproliferative disorders remains obscure.
Abeya A Lotfi, Asmaa E Mohamed, Nahela A Shalaby, Deena S Eissa, Ehab El-Dabaa, Ayman M Sallam, Mahmoud M Kamel, Hisham Abdelaziz, Amal M El-Afifi, Ahmed S Abdel-Moneim   +9 more
doaj   +1 more source